Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5889 ARTÍCULOS , VIENDO DEL 2131 AL 2145

Monoamine neurotransmitters and movement disorders in children and adults

Doummar D, Moussa F, Nougues MC, Ravelli C, Louha M, Whalen S, Burglen L, Rodriguez D, Billette de Villemeur T.

Rev Neurol (Paris). 2018 Nov;174(9):581-588. doi: 10.1016/j.neurol.2018.07.002. Epub 2018 Aug 27.

Quality of life improvements in patients with cervical dystonia following treatment with a liquid formulation of abobotulinumtoxinA (Dysport(®) )

Simonetta-Moreau M, Picaut P, Volteau M, Poewe W.

Eur J Neurol. 2019 Jun;26(6):943-e65. doi: 10.1111/ene.13800. Epub 2018 Sep 30.

What a neurologist should know about PET and SPECT functional imaging for parkinsonism: A practical perspective

Thobois S, Prange S, Scheiber C, Broussolle E.

Parkinsonism Relat Disord. 2019 Feb;59:93-100. doi: 10.1016/j.parkreldis.2018.08.016. Epub 2018 Aug 30.

Motor and non-motor determinants of health-related quality of life in young dystonia patients

Eggink H, Coenen MA, de Jong R, Toonen RF, Eissens MH, Veenstra WS, Peall KJ, Sival DA, Elema A, Tijssen MA.

Parkinsonism Relat Disord. 2019 Jan;58:50-55. doi: 10.1016/j.parkreldis.2018.08.008. Epub 2018 Aug 29.

Effect of continuous intrathecal baclofen therapy in children: a systematic review

Buizer AI, Martens BHM, Grandbois van Ravenhorst C, Schoonmade LJ, Becher JG, Vermeulen RJ.

Dev Med Child Neurol. 2019 Feb;61(2):128-134. doi: 10.1111/dmcn.14005. Epub 2018 Sep 6.

A phase 2, randomized, placebo-controlled study of the efficacy and safety of TAK-063 in subjects with an acute exacerbation of schizophrenia

Macek TA, McCue M, Dong X, Hanson E, Goldsmith P, Affinito J, Mahableshwarkar AR.

Schizophr Res. 2019 Feb;204:289-294. doi: 10.1016/j.schres.2018.08.028. Epub 2018 Sep 3.

Lenalidomide induced reversible parkinsonism, dystonia, and dementia in subclinical Creutzfeldt-Jakob disease

Argente-Escrig H, Martinez JC, Gómez E, Balaguer A, Sevilla T, Bataller L.

J Neurol Sci. 2018 Oct 15;393:140-141. doi: 10.1016/j.jns.2018.08.027. Epub 2018 Aug 28.

Refining the phenotype associated with GNB1 mutations: Clinical data on 18 newly identified patients and review of the literature

Hemati P, Revah-Politi A, Bassan H, Petrovski S, Bilancia CG, Ramsey K, Griffin NG, Bier L, Cho MT, Rosello M, Lynch SA, Colombo S, Weber A, Haug M, Heinzen EL, Sands TT, Narayanan V, Primiano M, Aggarwal VS, Millan F, Sattler-Holtrop SG, Caro-Llopis A, Pillar N, Baker J, Freedman R, Kroes HY, Sacharow S, Stong N, Lapunzina P, Schneider MC, Mendelsohn NJ, Singleton A, Loik Ramey V, Wou K, Kuzminsky A, Monfort S, Weiss M, Doyle S, Iglesias A, Martinez F, Mckenzie F, Orellana C, van Gassen KLI, Palomares M, Bazak L, Lee A, Bircher A, Basel-Vanagaite L, Hafström M, Houge G; C4RCD Research Group; DDD study; Goldstein DB, Anyane-Yeboa K.

Am J Med Genet A. 2018 Nov;176(11):2259-2275. doi: 10.1002/ajmg.a.40472. Epub 2018 Sep 8.

The effect of a single botulinum toxin treatment on somatosensory processing in idiopathic isolated cervical dystonia: an observational study

De Pauw J, Cras P, Truijen S, Mercelis R, Michiels S, Saeys W, Vereeck L, Hallemans A, De Hertogh W.

J Neurol. 2018 Nov;265(11):2672-2683. doi: 10.1007/s00415-018-9045-y. Epub 2018 Sep 8.

An inherited KMT2B duplication variant in a Chinese family with dystonia and/or development delay

Dai L, Ding C, Fang F.

Parkinsonism Relat Disord. 2019 Jun;63:227-228. doi: 10.1016/j.parkreldis.2018.08.021. Epub 2018 Aug 31.

Long-term outcome of flexible onabotulinum toxin A treatment in facial dystonia

Bladen JC, Feldman I, Favor M, Dizon M, Litwin A, Malhotra R.

Eye (Lond). 2019 Mar;33(3):349-352. doi: 10.1038/s41433-018-0203-3. Epub 2018 Sep 10.

Differential effects of propranolol on head and upper limb tremor in patients with essential tremor and dystonia

Paparella G, Ferrazzano G, Cannavacciuolo A, Cogliati Dezza F, Fabbrini G, Bologna M, Berardelli A.

J Neurol. 2018 Nov;265(11):2695-2703. doi: 10.1007/s00415-018-9052-z. Epub 2018 Sep 12.

The first case of deafness-dystonia syndrome due to compound heterozygous variants in FITM2

Shakir A, Wadley AF, Purcarin G, Wierenga KJ.

Clin Case Rep. 2018 Jul 26;6(9):1815-1817. doi: 10.1002/ccr3.1719. eCollection 2018 Sep.

Deep brain stimulation for childhood dystonia: current evidence and emerging practice

Elkaim LM, De Vloo P, Kalia SK, Lozano AM, Ibrahim GM.

Expert Rev Neurother. 2018 Oct;18(10):773-784. doi: 10.1080/14737175.2018.1523721. Epub 2018 Sep 24.

Autosomal-recessive iron deficiency anemia, dystonia and hypermanganesemia caused by new variant mutation of the manganese transporter gene SLC39A14

Zeglam A, Abugrara A, Kabuka M.

Acta Neurol Belg. 2019 Sep;119(3):379-384. doi: 10.1007/s13760-018-1024-7. Epub 2018 Sep 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias